- 3 Top Altcoins Primed for a MEGA PUMP (ISO 20022 Compliant)
- Spot platinum has just surpassed the $1,760.00/oz mark, now quoted at $1,760.55/oz, up 1.59% on the day; Nymex platinum futures main contract is now quoted at $1,774.6/oz, up 1.06% on the day.
- Lexeo wins FDA RMAT designation for LX2020 in PKP2 arrhythmogenic cardiomyopathy
- Euro: PMI resilience tempers stagflation fears – BNY
- Freshpet says Q2 2026 sales, margin beat guidance on volume growth, lower input costs and plant leverage
- WATERS CORP <WAT.N>: TD COWEN RAISES TO BUY FROM HOLD; RAISES TARGET PRICE TO $475 FROM $408
- Aurora Cannabis 1Q Loss Narrows Despite Fall in Revenue
- Incap launches share buyback program worth up to EUR 15 million
- AFFIRM HOLDINGS, INC. : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $93 FROM $88
- Novo Nordisk CFO: We are ahead of schedule in achieving our company-wide transformation goal of 8 billion Danish kroner in cost savings.
- Lodestar Metals reports bulk-tonnage gold-silver potential at Gold Run project in Nevada
- Flugger issues 7,260 B shares to employees at DKK 20 via restricted share units
- Heights Capital lifts Faron Pharma stake to 20.72% voting rights
- Revenio board updates disclosure policy to reflect EU Market Abuse Regulation changes
- W5 Solutions posts webcast presentation for January-June 2026 interim report
- Banco Mercantil publishes 2Q26 results presentation
- InPlay Oil lifts 2026 free adjusted funds flow outlook to CAD 79 million-CAD 89 million
- Lithium Argentina unit Cauchari-Olaroz closes USD 220 million unsecured debt facilities
- ROLLINS INC <ROL.N>: ARGUS RESEARCH CUTS TO HOLD FROM BUY
- MARATHON PETROLEUM CORPORATION <MPC.N>: TD COWEN RAISES TARGET PRICE TO $375 FROM $357
- EVgo Q2 FY26 net loss widens 55% to USD 46.34 million; revenue falls 16% to USD 82.65 million
- DIGITAL REALTY TRUST, INC. <DLR.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- Centurion Accommodation REIT 1H FY26 DPU rises 9.6% to 3.499 cents; revenue climbs 5.1% to S$108.94 million
- Griffon FY26 Q3 operating income swings to USD 115.5 million; revenue rises 7% to USD 481.4 million
- WORKIVA INC. <WK.N>: RAYMOND JAMES CUTS TARGET PRICE TO $80 FROM $85
- AMGEN INC. : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $317.00 FROM $312.00
- LATTICE SEMICONDUCTOR <LSCC.O>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $125.00 FROM $105.00
- Gibraltar Industries Backs 2026 Sales $1.76B-$1.83B >ROCK
- Gibraltar Industries Backs 2026 EPS $2.40-EPS $2.80 >ROCK
- InPlay Oil in Definitive Agreement to Acquire Private Oil and Gas Producer for Cash Consideration of C$54.25M >IPO.T
- DAVITA INC <DVA.N>: BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $170.00 FROM $145.00
- ARISTA NETWORKS : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $240.00 FROM $200.00
- Great Pacific Gold starts drilling at Magiabe target at Wild Dog project in Papua New Guinea
- Holley Q2 FY26 turns to GAAP net loss of $2.4 million; net sales rise 3.2% to $172 million
- SPYRE THERAPEUTICS INC <SYRE.O>: RAYMOND JAMES RAISES TARGET PRICE TO $121 FROM $88
- Kane Biotech launches strategic review to pursue partnerships, financing, deals
- Alliança Saúde files for court confirmation of out-of-court reorganization plan covering BRL 1.1 billion in claims
- BRISTOL-MYERS SQUIBB COMPANY <BMY.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- NordX Metals confirms 11.3 m at 0.68% U3O8 in Finland’s Riutta uranium project resampling
- BRIEF-Griffon Q3 Revenue USD 481.4 Million Vs. IBES Estimate USD 457.8 Million
- REVOLVE GROUP INC <RVLV.N>: MORGAN STANLEY RAISES TARGET PRICE TO $29.00 FROM $27.00
- COMPASS, INC. <COMP.N>: MORGAN STANLEY RAISES TARGET PRICE TO $14.00 FROM $12.50
- Volatus Aerospace partners with Kraus Hamdani to bring K1000ULE autonomous aircraft to Canada
- MARATHON PETROLEUM CORPORATION <MPC.N>: RAYMOND JAMES RAISES TARGET PRICE TO $350 FROM $335
- ZETA GLOBAL HOLDINGS CORP <ZETA.N>: MORGAN STANLEY RAISES TARGET PRICE TO $25.00 FROM $23.00
- MATCH GROUP INC <MTCH.O>: MORGAN STANLEY RAISES TARGET PRICE TO $40.00 FROM $38.00
- FLYWIRE CORP <FLYW.O>: MORGAN STANLEY RAISES TARGET PRICE TO $22.00 FROM $20.00
- ADVANCED MICRO DEVICES : MORGAN STANLEY RAISES TARGET PRICE TO $465.00 FROM $410.00
- FIDELITY NATIONAL INFORMATION SERVICES <FIS.N>: MORGAN STANLEY CUTS TARGET PRICE TO $46.00 FROM $47.00
- Oreterra Metals begins trading on OTCQB Venture Market under OTMCF symbol
- ARISTA NETWORKS : MORGAN STANLEY RAISES TARGET PRICE TO $220.00 FROM $190.00
- SHOALS TECHNOLOGIES GROUP <SHLS.O>: MORGAN STANLEY RAISES TARGET PRICE TO $10.00 FROM $9.00
- CERTARA INC <CERT.O>: MORGAN STANLEY CUTS TARGET PRICE TO $9.00 FROM $10.00
- VOYAGER TECHNOLOGIES INC <VOYG.N>: MORGAN STANLEY CUTS TARGET PRICE TO $37.00 FROM $39.00
- AMERICAN WELL : MORGAN STANLEY RAISES TARGET PRICE TO $13.00 FROM $6.50
- BRS Resources signs deal to earn 75% stake in Sonora gold-silver concessions with US$5 million spend commitment
- PINTEREST INC : MORGAN STANLEY RAISES TARGET PRICE TO $32.00 FROM $30.00
- DIANTHUS THERAPEUTICS INC <DNTH.O>: RAYMOND JAMES RAISES TARGET PRICE TO $131 FROM $125
- ASTERA LABS INC : MORGAN STANLEY RAISES TARGET PRICE TO $382.00 FROM $335.00
- QUALYS INC <QLYS.O>: MORGAN STANLEY RAISES TARGET PRICE TO $130.00 FROM $115.00
- ARCHER DANIELS MIDLAND : MORGAN STANLEY RAISES TARGET PRICE TO $79.00 FROM $60.00
- ARCHER DANIELS MIDLAND : MORGAN STANLEY RAISES TARGET PRICE TO $79.00 FROM $60.00
- BLACKLINE INC <BL.O>: MORGAN STANLEY CUTS TARGET PRICE TO $30.00 FROM $33.00
- Gibraltar FY26 Q2 GAAP EPS falls 7.1% to $0.92; net sales rise 64.6% to $509.5 million
- TERADATA <TDC.N>: MORGAN STANLEY CUTS TARGET PRICE TO $35.00 FROM $40.00
- CRICUT INC <CRCT.O>: MORGAN STANLEY RAISES TARGET PRICE TO $3.70 FROM $3.10
- AMGEN INC. : MORGAN STANLEY RAISES TARGET PRICE TO $351.00 FROM $333.00
- CALLAWAY GOLF CO <CALY.N>: MORGAN STANLEY RAISES TARGET PRICE TO $19.00 FROM $17.00
- Medline Q2 FY26 net income drops 58.3% to $139 million; net sales rise 11.6% to $7.7 billion
- Medline 2Q EPS 7c >MDLN
- XPEL Sees 3Q Rev $137M-$139M >XPEL
- Gibraltar Industries 2Q Cont Ops EPS 92c >ROCK
- Medline 2Q Sales $7.69B >MDLN
- Medline 2Q Net $139M >MDLN
- Bioventus Backs 2026 Adj EPS 75c-Adj EPS 79c >BVS
- EVgo Sees FY26 Rev $400M-$430M >EVGO
- Griffon 3Q Adj EPS $1.51 >GFF
- Griffon 3Q EPS $1.14 >GFF
- Gibraltar Industries 2Q Adj EPS $1.11 >ROCK
- Bioventus Backs 2026 Sales $600M-$610M >BVS
- Bioventus 2Q Adj EPS 22c >BVS
- Immuneering Expects Cash Runway to Be Sufficient to Fund Ops Into 2029 >IMRX
- Bioventus 2Q Sales $153.2M >BVS
- Bioventus 2Q EPS 47c >BVS
- Rambus Initiates $100 Million Accelerated Share Repurchase Program >RMBS
- Gibraltar Industries 2Q Sales $509.5M >ROCK
- Gibraltar Industries 2Q EPS 92c >ROCK
- XPEL 2Q EPS 65c >XPEL
- Immuneering 2Q Loss/Shr 27c >IMRX
- Aurora Cannabis FY27 Q1 net loss narrows to C$ 4.03 million; revenue falls 12.11% to C$ 70.76 million
- Tritech Group says placement agreement lapses after conditions unmet by cut-off date
- Charbone expects Q2 gas income to rise 155% to $0.5 million
- CVS Health 2Q Front Store Same-Store Sales Up 1.0% >CVS
- CVS Health 2Q Pharmacy Same-Store Sales Up 2.9% >CVS
- CVS Health 2Q Same-Store Sales Up 2.6% >CVS
- BorgWarner Reports Strong Second Quarter 2026 Results, Increases 2026 Adjusted EPS Guidance And Share Repurchase Authorization By $1 Billion, And Announces 7 Awards Across Portfolio To Support Long-Term Profitable Growth >BWA
- BorgWarner 2Q Adj EPS $1.42 >BWA
- BorgWarner 2Q Net $277M >BWA
- BorgWarner Sees FY Adj EPS $5.05-Adj EPS $5.30 >BWA
- CVS Health 2Q Net $2.98B >CVS
